Persistent tunica vasculosa lentis

Editor-In-Chief: Prab R Tumpati, MD
Obesity, Sleep & Internal medicine
Founder, WikiMD Wellnesspedia &
W8MD's weight loss doctor NYC
Philadelphia GLP-1 weight loss and GLP-1 clinic NYC

Persistent tunica vasculosa lentis
Synonyms	Persistent fetal vasculature
Pronounce	N/A
Specialty	N/A
Symptoms	Leukocoria, strabismus, nystagmus, amblyopia
Complications	Cataract, glaucoma, retinal detachment
Onset	Infancy
Duration	Chronic
Types	N/A
Causes	Developmental anomaly
Risks	Premature birth, genetic disorders
Diagnosis	Ophthalmic examination, ultrasound, MRI
Differential diagnosis	Retinoblastoma, congenital cataract, Coats' disease
Prevention	N/A
Treatment	Surgery, laser therapy
Medication	N/A
Prognosis	Variable, depends on severity and treatment
Frequency	Rare
Deaths	N/A

Persistent tunica vasculosa lentis (PTVL) is a rare ophthalmological condition characterized by the incomplete regression of the tunica vasculosa lentis, a vascular network that supplies the developing lens of the eye during embryogenesis. This condition can lead to various visual impairments, including cataracts, glaucoma, and microphthalmia.

Etiology

The exact cause of PTVL is not well understood. It is believed to be associated with genetic factors, as it has been observed in certain familial clusters. Some researchers suggest that it may be linked to mutations in the FOXE3 gene, which plays a crucial role in eye development.

Pathophysiology

During normal embryogenesis, the tunica vasculosa lentis forms to provide nutrients to the developing lens. By the third trimester of pregnancy, this network typically regresses completely. In cases of PTVL, this regression is incomplete, leading to a persistent vascular network that can interfere with the normal development and function of the eye.

Clinical Presentation

Patients with PTVL often present with visual disturbances such as blurred vision or decreased visual acuity. Physical examination may reveal a cloudy or opaque lens (cataract), increased intraocular pressure (glaucoma), or a smaller than normal eye (microphthalmia). In severe cases, PTVL can lead to blindness.

Diagnosis

Diagnosis of PTVL is typically made based on clinical findings and confirmed with imaging studies such as ultrasonography or MRI. Genetic testing may also be performed to identify potential genetic mutations associated with the condition.

Treatment

Treatment for PTVL is primarily aimed at managing the associated conditions and improving visual function. This may include surgical removal of cataracts, medication or surgery to manage glaucoma, and visual rehabilitation therapies.

Prognosis

The prognosis for PTVL varies depending on the severity of the condition and the associated visual impairments. With early diagnosis and appropriate treatment, many patients can achieve improved visual function.

See Also

• Persistent hyperplastic primary vitreous
• Microphthalmia
• Cataract
• Glaucoma